126 related articles for article (PubMed ID: 210180)
1. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
Wright DE; Hruby VJ; Rodbell M
J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
[TBL] [Abstract][Full Text] [Related]
2. Glucagon1-6 binds to the glucagon receptor and activates hepatic adenylate cyclase.
Wright DE; Rodbell M
J Biol Chem; 1979 Jan; 254(2):268-9. PubMed ID: 216670
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
Pelton JT; Trivedi D; Hruby VJ
Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
Frandsen EK; Thim L; Moody AJ; Markussen J
J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
Lin MC; Wright DE; Hruby VJ; Rodbell M
Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
[TBL] [Abstract][Full Text] [Related]
8. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
Carrey EA; Epand RM
J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
[TBL] [Abstract][Full Text] [Related]
9. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
Liepnieks JJ; Epand RM
Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
[TBL] [Abstract][Full Text] [Related]
10. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
Wright DE; Rodbell M
J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
[TBL] [Abstract][Full Text] [Related]
11. Solubilization and separation of the glucagon receptor and adenylate cyclase in guanine nucleotide-sensitive states.
Welton AF; Lad PM; Newby AC; Yamamura H; Nicosia S; Rodbell M
J Biol Chem; 1977 Sep; 252(17):5947-50. PubMed ID: 197078
[TBL] [Abstract][Full Text] [Related]
12. Coupling of the glucagon receptor to adenylate cyclase.
Houslay MD
Biochem Soc Trans; 1979 Oct; 7(5):843-6. PubMed ID: 229036
[No Abstract] [Full Text] [Related]
13. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
[TBL] [Abstract][Full Text] [Related]
14. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
Hruby VJ
Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
[TBL] [Abstract][Full Text] [Related]
15. The glucagon receptor and adenylate cyclase.
Levey GS
Metabolism; 1975 Mar; 24(3):301-10. PubMed ID: 165352
[TBL] [Abstract][Full Text] [Related]
16. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
[TBL] [Abstract][Full Text] [Related]
18. Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.
Lad PM; Welton AF; Rodbell M
J Biol Chem; 1977 Sep; 252(17):5942-6. PubMed ID: 197077
[No Abstract] [Full Text] [Related]
19. Glucagon: structure-function relationships investigated by sequence deletions.
Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
[TBL] [Abstract][Full Text] [Related]
20. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
Wright DE; Hruby VJ; Rodbell M
Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
